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Tissue Enzymes 
Phillip T. Pearson, D.V.M., Ph.D.* 
The transaminase enzyme was first dis-
covered by Braunstein and Kritzman in 
1938 in pigeon breast muscle. This en-
zyme was later purified by Cohnen in 
1940. In 1941, Cohnen (4) showed that 
the enzyme transaminase was particularly 
abundant in cardiac and skeletal muscle. 
It was this observation that led La Due 
(13) and his associates to estimate serum 
levels of transaminase following myocard-
ial infarction with the idea that the necro-
tic myocardium would be likely to liberate 
aminopherase into the blood stream. They 
also discovered that hepatitis and skeletal 
muscle necrosis were responsible for ele-
vated serum levels of the enzyme. 
The first determinations of transamin-
ase levels were tedious and inaccurate un-
til 1951 when Cammarata and Cohnen de-
vised a photometric determination. In 
1954 Karmen, Wroblewski and La Due 
described an accurate, reproducable 
method employing paper chromatography 
but this was still a long procedure requir-
ing over 36 hours for one determination. 
At the same time Karmen (9) and work-
ers described a photometric method that 
was simple, inexpensive, accurate, ex-
tremely reproducable and required one 
hour to run. The Sigma methods of trans-
aminase determinations are modifications 
of the Karmen technique and they can be 
run with any spectrophotometer or any 
colorimeter which is fitted with a light 
filter in the range of 490 to 520 m u. 
These initial observations made by La 
Due, Wroblewski and Karmen (13) have 
been confirmed both in man (3,10,14,15, 
18 & 19) and under experimental condi-
tions in animals. (1,9,15,16,18 & 20) It 
has also been demonstrated that infarc-
tions produced by ligation of the pulmon-
ary, renal, splenic and mesenteric arteries 
may produce elevated serum transaminase 
levels. 
* Dr. Pearson is an Assistant Professor of Veterinary 
Medicine and Surgery, College of Veterinary Medi· 
cine, Iowa State University, Ames, Iowa. 
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Most of the work done with tissue en-
zymes has been with serum glutamic oxa-
loacetic transaminase (SOG-T) and its im-
portance in myocardial infarcts. As a re-
sult of this work, other important enzymes 
have been discovered such as: serum aldo-
lase (SA), lactic dehydrogenase (LD), 
serum glutamic pyruvic transaminase 
(SGP-T), serum malic dehydrogenase 
( SMD), phosphohexose isomerase (PI), 
adenosine triphosphatase and lipoprotein 
lipase. Serum aldolase and lactic dehydro-
genase are effective in the diagnosis of 
myocardial infarction. Serum glutamic 
pyruvic transaminase is very good in aid-
ing in the diagnosis of hepatitis, but is less 
effective in the diagnosis of cardiac necro-
sis (2), More work needs to be done on 
serum malic dehydrogenase and phospho-
hexose isomerase before their true value 
will be known. It was found that adenosine 
triphosphatase and lipoprotein lipase were 
of no clinical value (19). 
Besides showing elevated serum levels 
with myocardial infarction, SGO-T shows 
a similar high serum level with a number 
of disease conditions in man and animals 
( 12), Some of these conditions are: car-
diac arrhythmias with ventricular rates of 
160 or more, acute hepatitis, hepatic cirr-
hosis, obstructive jaundice, 50% of the 
pancreatic cases, 75% of the jaundice 
cases, muscle crush injuries, extremity 
embolus, pulmonary emoblism, surgical 
trauma, prolonged shock, hemolytic crisis, 
dermatomyositis and experimental liga-
tion of renal, cardiac, mesenteric, splenic 
and pulmonary vessels. SGO-T was nor-
mal in conditions such as neoplastic dis-
eases, acute febrile and chronic infections, 
uremia, pulmonary infarctions, stress, 
metabolic diseases and congenital diseases 
unless there was heart, liver, muscle or 
kidney necrosis (13). 
Clinical Usc of Enzymes 
In man the diagnosis of acute myo-
cardial infarction can in most instances 
be established by a correlation of clinical, 
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laboratory and electrocardiagraphic evi-
dence. There is nevertheless a significant 
number of cases in which an unequivocal 
diagnosis is not possible. The elevation of 
serum enzymes following myocardial in-
farction appears to offer a new objective 
test for establishing this diagnosis. In 
certain cases Ostrow (17) and his work-
ers felt it was more useful than the EKG. 
Two examples were in the left bundle-
branch blocks where the electrocardio-
graphic picture was masked or distorted 
and in the extension of a myocardial in-
farct. La Due and Wroblewski (12) found 
a significant correlation between the 
SGO-T level and the EKG estimated size 
of the infarct. 
In experimental work with dogs, Corne-
lius et al. (5,6,7) and Crawley (8) have 
done the most work. Cornelius' work in-
dicated that the SGO-T enzyme should be 
of diagnostic value for canine and feline 
myocardial necrosis and SGP-T should be 
of value as an indicator of liver necrosis 
in both species. Crawley stated that SGO-T 
was of value in diagnosing cardiac necro-
sis, but was of no positive value in cases 
of epicarditis or valvular insufficiency. 
The serum enzyme levels were found to 
rise roughly in proportion to the amount 
of infarcted tissue while the concentration 
of the enzyme in the tissue decreased in 
proportion to the age of the infarct. The 
enzyme levels rose 2 to 20 times their nor-
mal serum levels. The peak of the serum 
enzyme level was reached in 36 to 48 
hours and the level was usually back to 
normal in three to five days. An infarction 
of as little as 5 to 10% of the total myo-
cardium or liver was associated with sig-
nificant rises in transaminase levels. 
Serial determinations of serum enzyme 
levels are the most satisfactory. The first 
check should be begun as soon as possible 
after the infarction. Then two samples 
should be drawn at 12 hour intervals and 
two more at 24 hour intervals for a total 
of five samples in 72 hours. If only one 
test is possible, it should be taken some-
where between 24 and 48 hours after the 
onset of symptoms. 
In clinical cases (11), there did not 
appear to be any consistent relationship 
between the enzyme level and the blood 
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sedimentation rate, leucocyte count, pro-
tein or fibrinogen content of the serum, 
location of infarct, use of anticoagulants, 
digitalis, antibiotics, sedatives or pressor 
agents. Kattus et al. (10) showed that the 
SGO-T peak was about two days ahead of 
the temperature, leucocyte count and 
blood sedimentation rate peaks. La Due 
and Wroblewski (12) were unable to find 
any correlation between the height of the 
SGO-T level and the age, sex, color, weight, 
temperature, leucocyte count, blood sedi-
mentation rate, presence of shock, blood 
pressure, presence of heart failure, loca-
tion of infarct or mortality rate of the pa-
tient. They also found that although the 
brain was high in SGO-T, brain damage 
failed to cause a serum elevation, prob-
ably because of a blood brain barrier. 
The enzymes indicate not only the se-
verity of the disease but because of their 
rapid increase in the serum, they fre-
quently suggest the presence of acute in-
farction prior to the occurrence of diag-
nostic electrocardiographic changes and 
liver function tests. However, they still 
leave much to be desired since they return 
to normal levels on about the fifth day of 
the disease and give no information as to 
the further course of the illness, unless an 
extension of the initial infarction occurs 
(21 ). 
Current Clinical Methods for 
Analysis of Enzymes 
For a veterinarian in practice, a colori-
metric test such as the kits made by 
Sigma * or Omni * * can be used. If pre-
ferred and available, serum samples can 
be submitted to a local medical laboratory 
for enzyme analysis. In either case the 
blood for these enzyme checks must be 
drawn carefully to avoid hemolYSis which 
affects the readings. The temperature 
must be watched closely and the testing 
should be done at a uniform temperature. 
The serum can be separated from the cells 
and stored at refrigerator temperatures 
for four days before being analyzed. The 
enzymes are stable at refrigerator temp-
eratures for at least four days and they 
lose very little activity in 30 days. 
* SiJ:ma Chemical Company, 3500 DeKalb Street St. 
Louis 18. Missouri. • 
.. Omni Tech, Sun Valley, California. 
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Normal Canine Enzyme Levels 
The units given below were compiled 
from the blood enzyme level determina-
tions from 25 apparently healthy dogs 
that were given a physical examination 
coupled with clinical laboratory tests. The 
laboratory work consisted of an erythro-
cyte count, leucocyte count, leucocyte dif-
ferential count, hematocrit reading, hemo-
globin reading, blood sedimentation rate, 
urine specific gravity, urine pH, urine al-
bumin, urine sugar, urine sediment and 
methylene blue liver function test. 
Employing the Sigma Kit and a number. 
401 A Lumetron Colorimeter* with a 490 
mu light filter, the SGO-T units ranged 
from 14 to 48 Sigma-Frankel units with 
an average of 26 units. The SGP-T units 
ranged from 4 to 30 Sigma-Frankel units 
with an average of 19 units. With the 
Omni Test Kit, the SGO-T units ranged 
from 16 to 45 units with an average of 25 
units. The SGP-T units ranged from 6 to 
28 units with an average of 18 units. In 
all of these one unit is equal to the amount 
of transaminase activity necessary to pro-
duce a decrease in the optical density at 
340 mu of 0.001 per minute per m!. of 
serum under the conditions of Karmen 
(9) at 25 C per cm. of light path. 
Summary 
As with all other clinical laboratory 
tests, tissue enzyme levels should only be 
used as an aid to the diagnosis. Unless 
the entire picture including the symptoms, 
history and other laboratory tests are con-
sidered, the full value of the tissue en-
zymes will not be realized. Although there 
is still much to be understood about tissue 
enzymes in canine clinical work, it is now 
known that SGO-T can be of definite value 
in the clinical diagnosis of myocardial in-
farction and SGP-T can be useful in the 
clinical diagnosis of liver infarction. 
* Photovolt Corporation, 1115 Broadway, New York 
10, N. Y. 
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TRICHINOSIS 
1962 was the first year since 1956 that 
no cases of human trichinosis were re-
ported in Iowa. Typically, trichinosis is 
reported in small groups of cases that have 
developed in persons who have eaten im-
properly cooked pork. For example, the 
19 cases that were reported in 1961 were 
all from one source of infection. The of-
fending food was home-made, uncooked, 
smoked pork sausage. While the rate of 
trichinosis in hogs is declining, the in-
fection still exists. 
Pork is a highly nutritious, tasty food, 
but it always should be cooked well done 
before it is eaten. 
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